ARCA biopharma Inc (ABIO)
3.23
-0.04
(-1.22%)
USD |
NASDAQ |
Apr 17, 16:00
3.23
0.00 (0.00%)
After-Hours: 20:00
ARCA biopharma Cash from Financing (TTM): 0.00 for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 23.09M |
September 30, 2021 | 24.08M |
June 30, 2021 | 66.13M |
March 31, 2021 | 71.54M |
December 31, 2020 | 48.45M |
September 30, 2020 | 47.35M |
June 30, 2020 | 5.858M |
March 31, 2020 | 3.596M |
December 31, 2019 | 6.56M |
September 30, 2019 | 6.577M |
June 30, 2019 | 6.009M |
March 31, 2019 | 2.652M |
December 31, 2018 | 3.104M |
September 30, 2018 | 3.216M |
June 30, 2018 | 7.163M |
March 31, 2018 | 9.158M |
December 31, 2017 | 5.847M |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | -0.058M |
June 30, 2016 | -0.258M |
March 31, 2016 | 34.05M |
December 31, 2015 | 33.99M |
September 30, 2015 | 34.05M |
June 30, 2015 | 34.20M |
March 31, 2015 | -0.165M |
December 31, 2014 | 8.023M |
September 30, 2014 | 8.025M |
June 30, 2014 | 8.021M |
March 31, 2014 | 25.90M |
December 31, 2013 | 19.16M |
September 30, 2013 | 19.66M |
June 30, 2013 | 20.39M |
March 31, 2013 | 2.505M |
December 31, 2012 | 1.055M |
September 30, 2012 | 1.973M |
June 30, 2012 | 1.259M |
March 31, 2012 | 3.811M |
December 31, 2011 | 3.871M |
September 30, 2011 | 2.445M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
Mar 2022
71.54M
Maximum
Mar 2021
16.28M
Average
5.858M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
Shockwave Medical Inc | 600.40M |
Asensus Surgical Inc | 9.626M |
Glaukos Corp | 15.04M |
Helius Medical Technologies Inc | 1.077M |
Perspective Therapeutics Inc | 0.785M |